As it marks the 10th anniversary of the implementation of the national IP strategy, the Chinese government has taken a step further to restructure the offices that administer various IP rights. This includes the implementation of a faster timeframe for patent examination, provisions to curb bad-faith filings and the introduction of the E-commerce Law.
Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens
An entity with sub-licensing rights is litigating with the re-vamped PIPCO’s patents in China, and some early validity results are encouraging
In an exclusive sit-down with IAM at the automaker’s headquarters, Yosuke Iida says that its latest royalty-free licence scheme can help transform the company’s business – and the environment
The iPhone giant’s portfolio is at the heart of the defence it plays when the subject of an assertion – and analysis shows that much of it has been acquired rather than grown organically
Ongoing royalty negotiations are revealed after US network operator reportedly notifies government. Why the conflict, which follows a 2016 dispute with T-Mobile, may alarm Nokia and Ericsson
The amendments of 23 April 2019 to the Trademark Law will come into effect on 1 November 2019. These changes are a promising next step in the Chinese government’s stand against bad-faith filings and trademark infringement in China.
The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century
Transfer of microfluidics tech comes as San Diego-based Illumina faces a fierce IP fight with an upstart Chinese rival
Osaka-based firm seeks to fend off Toughbook rival with design rights, a field of IP that Japanese policymakers are seeking to boost with legislative IP reforms currently under consideration
Assignments involving Korean tech giant and US software business demonstrate that it’s more than just NPEs that are interested in NPE assets
Trailing behind the Swiss giant are DowDuPont and Bayer, both of which have seen a drop in the value of their holdings
Food and drug authorities will take responsibility for criminal IP investigations, as government re-shuffle continues. It’s good news for pharma IP owners – others may have questions
Following successful invalidation petitions lodged by Vivo against the German company, industry sources tell IAM that Oppo, Xiaomi and Meizu also face SEP assertions in specialised IP courts
The Patent Office has proposed simplifications to Form 27, which plays a role in compulsory licensing and injunctions, after complaints by Ericsson, Nokia, Huawei and others